CardioComm Solutions, Inc.: CardioComm Solutions Completes Issuance of Shares for Debt CardioComm Solutions, Inc. (TSXV: EKG) (
CardioComm or the
Company ), a global medical provider of consumer heart monitoring and medical electrocardiogram (
ECG ) software solutions, announced that it has completed its previously announced issuance of shares for debt (see the Company s press releases dated April 27, 2021 and April 8, 2021 for further details).
Under debt settlement agreements, the Company has issued an aggregate of 3,353,644 common shares of the Company (
Shares ) to directors, employees and consultants of the Company to settle debt for services provided to the Company. The Shares are subject to a four month hold period that expires September 12, 2021, in accordance with the policies of the TSX Venture Exchange and applicable securities laws.
CardioComm Solutions, Inc.: CardioComm Solutions to Issue Shares for Debt and Issue Stock Options
CardioComm Solutions, Inc. (TSXV: EKG) (
CardioComm or the
Company ), a global medical provider of consumer heart monitoring and medical electrocardiogram (
ECG ) software solutions, announced the proposed issuance of shares for debt and the issuance of stock options.
Under debt settlement agreements, the Company will issue an aggregate of 2,947,394 common shares of the Company (
Shares ) to a director, employees and consultants of the Company at a deemed price of $0.055 per Share. The Shares will be provided to settle debt for services provided to the Company and will be subject to a four month hold period in accordance with applicable securities laws.
CardioComm Solutions, Inc.: CardioComm Solutions to Issue Shares for Debt and Issue Stock Options
CardioComm or the
ECG ) software solutions, announced the proposed issuance of shares and the issuance of stock options.
Under shares for debt agreements, the Company will issue an aggregate of 406,250 common shares of the Company (
Shares ) to directors of the Company at a deemed price of $0.06 per Share. The Shares will be provided to settle debt for service expenses and will be subject to a four month hold period in accordance with applicable securities laws.
The Company also granted 62,500 stock options to a director of the Company, each option exercisable at $0.06 per Share for five years from the date of grant and vesting immediately. The options are subject to the provisions of the Company s Stock Option Plan, the policies of the TSX Venture Exchange and applicable securities laws.
Data Bridge Market Research recently added “
Telehealth Market by manufacturers, regions, type and application, forecast to 2028” in his database. This research report focus on complete assessment of market and contains future trend, growth factors, attentive opinions, facts, historical data, statistically supported and industry-validated market data. Environmental concerns & regulatory guidelines regarding release of effluents through different industries.
Telehealth Market comprehensive coverage of underlying economic and technological factors under key trend analysis.
Europe telehealth market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to growing at a CAGR of 14.1% in the above-mentioned forecast period.